This inventor holds 1 USPTO granted patent. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Toshiro Shibano: Innovator in Heterocyclic Compounds
Introduction
Toshiro Shibano is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. His work focuses on creating innovative solutions for circulatory diseases.
Latest Patents
Toshiro Shibano holds a patent for a heterocyclic compound that exhibits serotonin 2-receptor antagonistic activity. This compound is represented by a specific formula and is designed to be useful in the prevention or treatment of various circulatory diseases, including ischemic heart diseases and cerebral vessel disturbances. The patent highlights the compound's selective activity and its potential applications in medical treatments.
Career Highlights
Shibano's career is marked by his dedication to research and development in the pharmaceutical industry. He is associated with Daiichi Pharmaceutical Co., Ltd., where he continues to innovate and contribute to advancements in drug development. His work has been instrumental in addressing critical health issues through scientific research.
Collaborations
Throughout his career, Toshiro Shibano has collaborated with esteemed colleagues, including Tsuyoshi Tanaka and Yoshiyuki Morishima. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Toshiro Shibano's contributions to the field of medicinal chemistry and his innovative patent for a heterocyclic compound underscore his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for new treatments for circulatory diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile